What You Should Know:
– NVIDIA announced the launch of a cloud service for medical imaging AI, designed to streamline and accelerate the development of specialized AI models.
– The NVIDIA MONAI cloud APIs, built on…
Continue Reading
These numbers are astounding.
Between 1999 and 2021, nearly 645,000 people died of an opioid overdose. That’s in 22 years. Since the end of the Revolutionary War in 1783, the cumulative deaths from all American…
INVEST 2024 will be back at the Ritz Hotel in Chicago, May 21-22, and we are once again on the hunt for novel startups who will pitch LIVE in front of venture capitalist judges….
Continue Reading
From time to time, the FDA convenes an outside group of experts to weigh in on an experimental drug or medical device, or to offer insight on a scientific matter that raises questions. The…
Continue Reading
From left to right: Marissa Plescia, reporter at MedCity News; and Merith Basey, executive director of Patients For Affordable Drugs
After much anticipation and a bevy of (ongoing) lawsuits, the U.S. government is finally beginning…
What You Should Know:
Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, announced the commercial launch of the Tapestri® Single-cell MRD (scMRD) AML Multiomics Assay.The company designed the scMRD AML Multiomics Assay to bring…
Continue Reading
Perspectives on the digital therapeutics industry tend to reveal the bias of the prognosticator as a glass-half-full optimist or glass-half-empty pessimist. Not enough clinical data vs. inadequate payer reimbursement. Many of the apps produced…
Continue Reading
What You Should Know:
AmerisourceBergen Corporation (NYSE: ABC), announced the rebranding of its name and stock ticker change to Cencora, Inc. (NYSE: COR).Under the new name Cencora, the company unifies its 46,000 employees – across…
Continue Reading
More than 1,300 oncology drugs are in the development pipeline, waiting to potentially embark on the long journey toward their commercial debut. This journey is usually an arduous one, made even more difficult by…
Continue Reading
The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and complete a series…
Continue Reading
